Sitewide Sale10% OFF everything until 15 SeptemberEnds in Shop the Sale →
Free Shipping on orders over $250 AUDDispatched from Melbourne, Australia — 3–7 business daysPlain, discreet packaging on every orderSecure Checkout, PayID & Card available
Buying Guides 7 min read9 September 2026

Tirzepatide Research Peptide Price Australia (vs Prescription Mounjaro Cost)

Research-grade Tirzepatide vial pricing in Australia compared with published prescription Mounjaro pharmacy costs — what's actually being priced, and why the two numbers describe different products.

Written by the Peptide Labs Research Team

This is part of our research peptide price breakdown series — start there for how pricing works across the whole catalogue.

If you're looking for prescription Mounjaro pricing: this page is about research-grade Tirzepatide sold for laboratory use, not the prescription medicine. If you want pharmacy or PBS pricing for the approved product, telehealth providers such as Holistica Health's Mounjaro cost guide cover that directly. This site does not sell, prescribe, or facilitate access to prescription Mounjaro.

Two Different Products

Tirzepatide exists in Australia as two entirely separate offerings:

1. Prescription Mounjaro — a TGA-approved medicine, available only via prescription from a doctor, dispensed through a pharmacy.

2. Research-grade Tirzepatide — an unapproved compound sold by suppliers, including this site, strictly for in-vitro laboratory research and not for human or veterinary use.

This site sells only the second category. Nothing on this page or anywhere else on this site is an offer of, substitute for, or alternative to the prescription medicine, and nothing here implies the research compound is interchangeable with it.

Research-Grade Tirzepatide: Current Vial Pricing

Tirzepatide — specification

Also sold as: LY3298176
Class
Incretin mimetic
Molecular target
GLP-1 + GIP
Sequence / structure
LY3298176, dual GIP/GLP-1 receptor agonist
Molecular formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular weight
~4813.5 Da
CAS number
2023788-19-2
Plasma half-life
~5 days
Published human evidence
Approved drug (some jurisdictions)
Studied in
Metabolic research · Insulin sensitivity research

View current Tirzepatide research vial pricing →

As with every compound in this catalogue, the live price on the product page is the current figure — this article doesn't quote a fixed dollar amount because vial pricing moves with input costs.

What Prescription Mounjaro Costs

Prescription Mounjaro is not listed on Australia's Pharmaceutical Benefits Scheme, so it's paid for privately. Published pricing from Australian telehealth and pharmacy sources generally sits in the region of $350–$650 per month depending on dose, with starter (2.5mg) doses at the lower end and higher maintenance doses toward the top — see Holistica Health's current Mounjaro cost breakdown for the up-to-date figure, since PBS status and pharmacy pricing both change.

Why These Numbers Aren't a Fair Comparison

A per-vial research price and a per-month prescription price aren't measuring the same thing, and putting them side by side would be misleading rather than informative:

Research-grade TirzepatidePrescription Mounjaro
Regulatory statusUnapproved research compoundTGA-approved medicine
How it's obtainedPurchased directly, no prescriptionPrescription + pharmacy dispensing
What's being pricedA vial of compound for laboratory useA month of clinically supervised, dosed medication
Intended useIn-vitro research onlyHuman therapeutic use, under medical supervision

Because the two products differ in regulatory status, intended use and how they're dispensed, a vial price and a monthly prescription cost cannot be meaningfully converted into one another, and this article does not attempt to do so.

Related Reading

Frequently Asked Questions

Is research-grade Tirzepatide the same as Mounjaro?

They contain the same active peptide, but they are different regulated products with different manufacturing, testing and approval standards. Research-grade Tirzepatide sold here is unapproved and supplied strictly for laboratory research, not for human use.

Can I use research-grade Tirzepatide instead of a Mounjaro prescription?

This article does not address that question and makes no recommendation either way. Research-grade Tirzepatide sold on this site is for in-vitro laboratory research only and is not intended for human or veterinary use.

Why is Mounjaro not covered by the PBS?

As of the most recent public reporting, Mounjaro is not listed on the PBS for any condition in Australia. See the linked telehealth source above for current PBS status, which can change.

Disclaimer: Research-grade Tirzepatide sold on this site is supplied strictly for in-vitro laboratory research and is not for human or veterinary use, and is not a substitute for, equivalent to, or facilitation of access to the prescription medicine Mounjaro. This article makes no efficacy, safety or outcome claims for either product, contains no dosing or administration guidance, and is not medical advice. Prescription pricing figures are drawn from third-party telehealth sources linked above and were current as of publication — verify directly before relying on them.

Shop Research-Grade Peptides

99%+ HPLC purity · COA verified every batch · Next-day dispatch to Melbourne

Shop All Peptides